(for a review see DAVIES and SMITH3)); they confer resistance to the organisms by inactivation of the antibiotic. It has been demonstrated that aminoglycoside modifying enzymes from Bacillus'' and Staphylococcus aureus4) can be efficiently cloned and expressed in Escherichia coll. The development of a cloning system for the genus Streptomyces in recent years5,6) provides the possibility of cloning and expressing genes from different sources in this important group of organisms. Several aminoglycoside modifying enzymes have been cloned in Streptomyces lividans7,8) and used to construct cloning vehicles9,10). Using these vectors the tyrosinase gene from S. antibioticus11), aminoglycoside modifying enzymes from S. fradiae2), S. glaucescens12) and genes involved in the biosynthesis of antibiotics13, 14, 24) have been cloned and expressed. We report here the cloning and expression of another APH(3')-III phosphotransferase, that of S. aureus in S. lividans, which extends the number of vector genes that can be applied.
Materials and Methods
Bacterial Strains and Plasmids S. lividans strain 132615) was used as host for all the transformation experiments described. Plasmid pAT48 is pBR322 harboring a cloned neomycin-kanamycin resistance gene derived from S. aureus plasmid pRN195616) and was used as a source for the aminoglycoside (3')-III phosphotransferase gene4). Plasmids pIJ702 and pIJ704, derivatives of the pIJ101 multicopy plasmid17) containing the tyrosinase gene from S. antibioticus in different orientations" were used as cloning vectors.
Culture Conditions and Transformation Procedure For protoplast preparation spores and mycelia] fragments of S. lividans were grown in yeastmalt extract medium containing sucrose 34°0, MgCl2 5 mm and glycine 0.5%5). Protoplast formation and transformations were carried out as described by THOMPSON et al. 9) , except that the transformed protoplasts were spread directly on regeneration medium without further washing according to KIESER et a1.17). Mycelia for cell-free extracts as well as for plasmid preparations were obtained from growth in Tryptic soya broth CMI129 (Oxoid). MIC (minimal inhibitory concentration) value determinations were done on yeast extract -malt extract agar") according to ONO et a1.10).
Detection of Transformants
Transformants were detected by the overlay method17) using 2.5 ml soft agar containing 200 pg/ml thiostrepton. Colonies containing inserts were isolated as clones unable to produce black melanin halos11). Direct selections were done using kanamycin at a concentration of 200 /cg/ml.
Plasmid Preparations and DNA Manipulations
Plasmids were isolated after alkaline lysis and phenol -chloroform extraction according to KIESER20). Restriction analysis and ligations were performed according to THOMPSON et al.8) . Restriction enzymes and T4 DNA ligase were of commercial source (BRL) and used according to the suppliers recommendations.
Agarose gel electrophoresis was carried out according to MANIATIS et al.10) using Tris-acetate or Tris-borate buffer.
Preparation of Cell-free Extracts Cell-free extracts were prepared according to BENVENISTE and DAVIES1). A ssay for Aminoglycoside-phosphotransferase Cell-free extracts were first tested for the presence of modifying enzymes using a biological test. Atypical inactivation reaction was prepared as follows: cell-free extract 250/4l, buffer containing per liter Tris-HCl pH 7.4 (2 mm), MgCl2 (0.8 mm), NH4Cl (0.1 mM), dithiothreitol (0.1 mM), ATP (0.3 mM) and antibiotic (0.15 mM); 250 l. The mixtures were incubated at 30°C for different times and the residual antibiotic activity was determined using S. aureus strain 209P as tester organism19). Radiochemical assays were carried out using the phosphocellulose paper binding method1) with [7- 32P]ATP as substrate.
Chemicals
All chemicals were of highest available purity grade from Sigma or Merck. 
Results

Construction of Recombinant Plasmids and Detection of Transformants
The strategy used to subclone the APH(3')-III phosphotransferase gene from plasmid pAT48 into the Streptomyces vectors pIJ702 and pIJ704 is summarized in Fig. 1 . Ligation mixtures were used to transform S. lividans protoplasts. White, thiostrepton resistant colonies due to insertional inactivation of the melanin gene were isolated and plasmid mini-lysates of such strains screened for inserts. Two transformants containing plasmids of the expected size were analysed by agarose gel electrophoresis after restriction with Hind III (Fig. 2) . The results confirm, that an insert containing the four expected Hind III restriction sites was present.
Properties of the Transformants Phenotypic Properties
The MIC values of the wild type strain S. lividans, transformants containing pIJ702, and the two in vitro constructs were determined against a variety of aminoglycoside antibiotics ( Table 1) . The results are consistent with the broad substrate range of the S. aureus phosphotransferase".
The gene dosage is apparently not sufficient to confer resistance to amikacin in vivo, but cell-free extracts of strains containing the hybrid plasmids phosphorylate this antibiotic (see later). This is probably due to the lower affinity (high Km value) of the APH(3')-III for amikacin2,3). Both recombinant constructions are very stable in S. lividans even after long term fermentation without selective pressure (not shown).
Enzymatic Properties
The aminoglycoside substrate profile of arninoglycoside phosphotransferase activity extracted from S. lividans transformants was determined ( Table 2 ). The profile is consistent with that found in S. aureus containing pRN1956 plasmid4). Tobramycin is, as expected, not a substrate for the phosphotransferase and the resistance levels in vivo against this antibiotic are unchanged ( KAN  AMI  BUT  RMS  PAR  NEO  LVDM  TOB   <4  <2  <5  10  10  <1  20  <5  <4  <2  <5  10  10  <1  20  <5  >150  >2<5  35  >300  >50  >40  >60  <5   >150  >2<5  35  >300  >50  >40  >60  <5 Abbreviations: KAN kanamycin, AMI amikacin, BUT butirosin, RMS ribostamycin, PAR paromomycin, NEO neomycin, LVDM lividomycin, TOB tobramycin. The results reported here confirm that a gene for aminoglycoside antibiotic modification originally derived from the Gram-positive bacterium S. aureus can act as antibiotic determinant in S. lividans.
The new resistance plasmids obtained by the cloning of the neomycin-kanamycin phosphotransferase from S. aureus into S. lividans confer an antibiotic resistance phenotype comparable to those due to the naturally occurring plasmid in S. aureus (Table 1) 4).
The phosphorylation profile using a variety of aminoglycoside antibiotics confirms that the cloned gene corresponds to an APH(3') type III aminoglycoside phosphotransferase (lack of phosphorylation with tobramycin as substrate, but ability to phosphorylate both butirosin and lividomycin, Table 2 )3). The fragment containing the APH(3')-III gene was expressed in both orientations into the BglII site with respect to the mel gene orientation into pIJ702 and pIJ704 ( Fig. 1) , therefore we can exclude expression controlled by the promotor of the melanin gene. On the other hand we cannot exclude expression coming from a vector plasmid promotor reading counter clockwise through the Pst I site (Fig. 1) . The gene is in opposite orientation with respect to the tetR and ampR genes from the E. coli plasmid pBR322 and the start of the phosphotransferase coding sequence is preceded from 779 E. coli base pairs followed by 1,288 base pairs of S. aureus DNA22).
This could support the idea, that translational regulatory sequences from S. aureus are recognised by S. lividans. On the other hand no obvious homologies exist between the pre-gene sequence of a APH 3' phosphotransferase from S. fradiae and the ribosome binding site or promoter sequences found in other bacterial systems22,23). In contrast the S. aureus APH 3' pre-and post-gene sequences contain signal sequences closely resembling to those observed for other bacterial and bacteriophage genes16,22). Since the S. aureus gene has been sequenced16) the function of the regulatory regions can now be studied in Streptomyces.
The cloning and expression of the typical S. aureus APH(3')-III in Streptomycetes, provides a useful, broad substrate selective marker for cloning in this species. The staphylococcal gene expresses high level resistance to a number of aminoglycoside antibiotics and since the gene has only limited nucleic acid homology with analogous Streptomycete genes18), the APH(3')-III can be used in studies of antibiotic production in organisms containing an amplified phosphotransferase gene that is less susceptible to loss as a result of recombination between plasmid and chromosome.
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